CDT Equity (CDT) Stock: Buy, Sell, or Hold?
CDT - CDT Equity Inc. Common Stock
$0.93
0.01 (1.35%)
β²
5d:
-35.86%
30d:
+48.79%
90d:
+110.53%
WAIT
LOW Confidence
Analysis Updated: Oct 6, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When CDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: CDT is down 35.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: CDT is down 35.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CDT is currently trading at $0.93, which is considered fair relative to its 30-day fair value range of $0.11 to $1.55.
Technical Outlook: Technically, CDT is in a strong downtrend. Immediate support is located at $0.07, while resistance sits at $1.88.
Market Sentiment: CDT scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CDT is in a strong downtrend. Immediate support is located at $0.07, while resistance sits at $1.88.
Market Sentiment: CDT scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.11 -
$1.55
Company Quality Score
31/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
38.2%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (5/100)
- WARNING: Composite score 31/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.11 -
$1.55
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.07
Resistance Level
$1.88
Current Trend
Strong Downtrend
Technical data as of
Oct 6, 2026
Fundamental Context
Share & Embed Analysis
Last updated: October 07, 2026 6:22 AM ET
Data refreshes hourly during market hours. Next update: 7:22 AM
Data refreshes hourly during market hours. Next update: 7:22 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CDT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
23 analysts |
$139 | 57 HOLD |
|
DNTH
Dianthus Therapeutics In⦠|
STRONG BUY
16 analysts |
$141 | 59 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
20 analysts |
$116 | 60 HOLD |
|
SLDB
Solid Biosciences LLC |
STRONG BUY
13 analysts |
$19 | 63 BUY |